Antidepressant Use During Breastfeeding
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The treatment of breastfeeding mothers with depression raises several dilemmas, including the possible risk of drug exposure through breast milk for the infant. This article provides background information and presents practical advice and recommendations for the clinician dealing with the treatment of depression and related disorders in the postpartum period. METHODS: An electronic search for relevant articles was performed. As the use of tricyclic antidepressants has considerably decreased during the last decade and no new information on breastfeeding has emerged for the tricyclics in this period, this review exclusively focuses on the newer, non-tricyclic compounds. RESULTS: Most newer antidepressants produce very low or undetectable plasma concentrations in nursing infants. The highest infant plasma levels have been reported for fluoxetine, citalopram and venlafaxine. Suspected adverse effects have been reported in a few infants, particularly for fluoxetine and citalopram. CONCLUSIONS: Infant exposure of antidepressants through breast milk is generally low to very low. We consider that when antidepressant treatment is indicated in women with postpartum depression, they should not be advised to discontinue breastfeeding. Paroxetine and sertraline are most likely suitable first-line agents. Although some concern has been expressed for fluoxetine, citalopram and venlafaxine, we nevertheless consider that if the mother has been treated with one of these drugs during pregnancy, breast-feeding could also be allowed during continued treatment with these drugs in the postpartum period. However, an individual risk-benefit assessment should always be performed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Murray, L., Fiori-Cowley, A., Hooper, R., & Cooper, P. (1996) · Child Development · doi:10.2307/1131637 · Cited by 1,311
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
Wisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666 · cited 1×
“Several studies have shown improvements in postpartum depressive symptoms resulting from treatment with selective serotonin reuptake inhibitors (SSRIs), such as sertraline [17], fluvoxamine [18] and fluoxetine [19], and the SSRIs are thus considered first-line therapy in postpartum depression [20].”
Anxiety Disorders During Pregnancy and the Postpartum Period: A Systematic Review
Ross, L. E., & McLean, L. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0818 · Cited by 611 · cited 1×
“Due to few studies only very limited data are available to guide clinical interventions for women with or at risk for having perinatal anxiety disorders [9].”
BackgroundPoobalan, A. S., Aucott, L. S., Ross, L., Smith, W. C. S., Helms, P. J., & Williams, J. H. G. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.032789 · Cited by 238
Internalizing Behaviors in 4-Year-Old Children Exposed in Utero to Psychotropic Medications
Misri, S., Reebye, P., Kendrick, K., Carter, D., Ryan, D., Grunau, R. E., & Oberlander, T. F. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1026 · Cited by 207
Oberlander, T. F., Reebye, P., Misri, S., Papsdorf, M., Kim, J., & Grunau, R. E. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.1.22 · Cited by 198
Cornish, A. M., McMahon, C. A., Ungerer, J. A., Barnett, B., Kowalenko, N., & Tennant, C. (2005) · Infant Behavior and Development · doi:10.1016/j.infbeh.2005.03.004 · Cited by 180 · cited 2×
“In a study of 112 mother-infant pairs, chronic maternal depression in the first year postpartum was related to delayed psychomotor development in the infant at 15 months [5].”
BackgroundVenlafaxine in the Treatment of Postpartum Depression
Cohen, L. S., Viguera, A. C., Bouffard, S. M., Nonacs, R. M., Morabito, C., Collins, M. H., & Ablon, J. S. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0803 · Cited by 122 · cited 1×
“In addition, the serotoninnoradrenaline reuptake inhibitor (SNRI) venlafaxine has been found to reduce the symptoms of postpartum depression [22].”
Background
Cited by
Non-psychotic mental disorders in the perinatal period
Howard, L. M., Molyneaux, E., Dennis, C.-L., Rochat, T., Stein, A., & Milgrom, J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61276-9 · Cited by 1,328
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“If antidepressant treatment is indicated, sertraline or paroxetine is preferred [1136].”
BackgroundMcAllister-Williams, R. H., Baldwin, D. S., Cantwell, R., Easter, A., Gilvarry, E., Glover, V., Green, L., Gregoire, A., Howard, L. M., Jones, I., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117699361 · Cited by 271
Depression during pregnancy and postpartum
Becker, M., Weinberger, T., Chandy, A., & Schmukler, S. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0664-7 · Cited by 263
Antidepressant treatment for postnatal depression
Molyneaux, E., Howard, L. M., McGeown, H. R., Karia, A. M., & Trevillion, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002018.pub2 · Cited by 171
Metadata
- Authors
- Oystein Berle, J., & Spigset, O.
- Venue
- Current Women's Health Reviews
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-02-01
- Volume
- 7
- Issue
- 1
- Pages
- 28-34
- ISSN
- 1573-4048 (ISSN-L)
- OpenAlex
- W2012406114
- Cited by
- 135
- References
- 10
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant Use During Breastfeeding. https://app.cochat.ai/papers/10.2174/157340411794474784
- The paper
- Oystein Berle, J., & Spigset, O. (2011). Antidepressant Use During Breastfeeding. Current Women's Health Reviews. https://doi.org/10.2174/157340411794474784
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.